Maine 2023-2024 Regular Session

Maine House Bill LD978

Introduced
3/2/23  
Refer
3/2/23  
Refer
3/2/23  
Engrossed
4/27/23  
Enrolled
4/27/23  

Caption

An Act to Maintain Legislative Oversight of the Maine Medical Use of Cannabis Program by Requiring Major Substantive Rulemaking

Impact

The bill has significant implications for the state's cannabis law framework. By requiring legislative approval for final adoption of rules that are considered 'major substantive', LD978 strengthens legislative control over the processes governing medical cannabis. This change is aimed at protecting the integrity of the program and ensuring that changes to rules are subject to comprehensive legislative scrutiny, potentially preventing arbitrary or hasty regulatory shifts. It is set to impact how the Maine Medical Use of Cannabis Program is managed and enforced moving forward.

Summary

LD978, titled 'An Act to Maintain Legislative Oversight of the Maine Medical Use of Cannabis Program by Requiring Major Substantive Rulemaking', introduces amendments to the regulation of medical cannabis in Maine. The bill emphasizes the necessity for legislative authorizations for the final adoption of major rules related to the program. This legislative framework aims to ensure greater oversight of the cannabis program, establishing a more transparent process for how rules are created and enforced, particularly affecting medical dispensaries and caregivers within the state.

Sentiment

Sentiment surrounding LD978 is generally positive among legislators who advocate for stronger oversight of cannabis policies. Supporters view the bill as vital for preventing misuse and ensuring that the cannabis program remains effective and aligns with public health interests. However, there may be concerns from some stakeholders within the cannabis industry about potential bureaucratic slowdowns or limitations that could arise from requiring additional legislative steps for rule adoption.

Contention

Key points of contention related to LD978 include discussions regarding the balance between regulatory oversight and operational flexibility for dispensaries. Some advocates argue that while oversight is necessary, the added layers of legislative approval could potentially lead to delays in the implementation of vital regulations needed to address evolving industry challenges. Opponents express concerns that excessive regulation could stifle the growth and accessibility of medical cannabis services, potentially impacting patients relying on these medicinal resources.

Companion Bills

No companion bills found.

Previously Filed As

ME LD832

An Act to Sustain the Medical Use of Cannabis Program

ME LD40

An Act to Protect Liberty and Advance Justice in the Administration and Enforcement of the Cannabis Legalization Act and the Maine Medical Use of Cannabis Act

ME LD383

An Act to Restore Legislative Oversight of Rulemaking

ME LD1840

An Act to Amend the Maine Medical Use of Cannabis Act

ME LD2185

Resolve, Regarding Legislative Review of Chapter 2: Medical Use of Cannabis Program Rule, a Major Substantive Rule of the Department of Administrative and Financial Services, Office of Cannabis Policy

ME LD2187

Resolve, Regarding Legislative Review of Chapter 10: Rules for the Administration of the Adult Use Cannabis Program, a Major Substantive Rule of the Department of Administrative and Financial Services, Office of Cannabis Policy

ME LD1744

An Act to Strengthen Accountability in Rulemaking by Providing for Legislative Oversight

ME LD1819

An Act to Create the Maine Medical Cannabis Advisory Commission and the Medical Cannabis Alternative Health Board

ME HB1051

Update provisions on the interim legislative oversight of administrative rulemaking.

ME LD83

An Act to Clarify State Policy Regarding Cannabis Paraphernalia in the Maine Medical Use of Cannabis Act and the Cannabis Legalization Act

Similar Bills

No similar bills found.